https://precivityad.com/news daily 0.75 2026-03-19 https://precivityad.com/news/c2n-highlights-first-use-of-its-emtbr-tau243-plasma-assay-in-evokeevoke-phase-3-dataset-for-prediction-of-cognitive-and-functional-decline-in-patients-with-early-symptomatic-adnbsp monthly 0.5 2026-03-19 https://precivityad.com/news/c2n-diagnostics-enters-south-korean-market-through-partnership-withbeaubrain-healthcare-to-offer-precivity-portfolio-of-blood-tests-tohelp-doctors-diagnose-alzheimers-disease monthly 0.5 2026-03-11 https://precivityad.com/news/c2n-diagnostics-awarded-rigorous-new-york-state-department-of-health-permit-expanding-ability-to-provide-its-blood-tests-tohelp-diagnose-alzheimers-disease monthly 0.5 2025-11-24 https://precivityad.com/news/c2n-diagnostics-and-washu-medicine-teams-receive-prestigious-award-from-human-proteome-organization monthly 0.5 2025-11-13 https://precivityad.com/news/c2n-submits-us-fda-regulatory-filing-for-its-alzheimers-disease-blood-test monthly 0.5 2025-10-02 https://precivityad.com/news/new-research-reinforces-c2ns-precivityad2-blood-test-as-a-highly-accurate-tool-to-detect-brain-amyloid-pathology-in-symptomatic-patients monthly 0.5 2025-09-25 https://precivityad.com/news/dynamic-growth-leads-c2n-diagnostics-to-expand-st-louis-headquarters-to-meet-global-need-for-answers-to-alzheimers-disease-nbspnbsp monthly 0.5 2025-09-03 https://precivityad.com/news/c2n-diagnostics-expands-the-precivityad2-alzheimers-disease-blood-test-intended-use-to-patients-50-years-and-older monthly 0.5 2025-08-25 https://precivityad.com/news/c2n-announces-major-global-expansion-adds-six-new-international-partners monthly 0.5 2025-08-07 https://precivityad.com/news/c2n-diagnostics-expands-portfolio-of-blood-tests-for-clinical-researchers-studying-alzheimers-disease-and-related-dementias monthly 0.5 2025-07-15 https://precivityad.com/news/samsung-invests-in-c2n-diagnostics monthly 0.5 2025-03-13 https://precivityad.com/news/k1e196pn490zw2wogr6sublpkxndp4 monthly 0.5 2025-02-24 https://precivityad.com/news/study-highlights-how-c2ns-precivityad2-blood-biomarker-test-use-improvesnbsp-clinical-decision-making-in-the-evaluation-for-alzheimers-disease-nbspnbsp monthly 0.5 2025-02-24 https://precivityad.com/news/first-canadian-clinic-to-offer-c2ns-precivityad2-blood-test-to-help-healthcare-providers-diagnose-alzheimers-disease-joining-global-community-in-embracing-breakthrough-technology monthly 0.5 2025-02-24 https://precivityad.com/news/c2n-diagnostics-partners-with-the-michael-j-fox-foundation-to-uncover-new-links-between-parkinsons-disease-lewy-body-dementia-andalzheimers-disease monthly 0.5 2025-02-24 https://precivityad.com/news/c2n-diagnostics-receives-15-million-program-related-investment-from-ghr-foundation-to-develop-tau-tangle-pathology-test-for-diagnosing-staging-alzheimers-disease monthly 0.5 2024-09-30 https://precivityad.com/news/c2n-receives-funding-from-diagnostics-accelerator-to-develop-a-decentralized-clinical-mass-spectrometry-solution-to-enable-high-performance-alzheimers-disease-testing-worldwide monthly 0.5 2024-09-25 https://precivityad.com/news/jama-publishes-landmark-clinical-study-showing-c2n-diagnostics-precivityad2-blood-test-markedly-improves-accuracy-of-ad-diagnosis-in-both-primary-care-and-specialized-memory-care monthly 0.5 2024-07-28 https://precivityad.com/news/c2n-diagnostics-says-fdas-approval-of-donanemab-highlights-its-role-in-helping-to-determine-alzheimers-disease-pathology monthly 0.5 2024-07-02 https://precivityad.com/news/c2ns-precivity-tests-are-now-offered-through-mayo-clinic-laboratories monthly 0.5 2024-06-27 https://precivityad.com/news/cn-diagnostics-expands-into-japan-through-mediford-corporation-partnership-with-precivity-blood-testing-foralzheimers-disease-and-brain-research-market monthly 0.5 2024-04-26 https://precivityad.com/news/study-finds-cn-diagnostics-precivityad-blood-test-provides-opportunities-for-robust-cost-savings-in-the-evaluation-of-patients-with-cognitive-impairment monthly 0.5 2024-04-01 https://precivityad.com/news/new-research-shows-the-precivityad2-blood-test-has-high-accuracy-compared-to-amyloid-pet-scans-in-individuals-with-cognitive-impairment monthly 0.5 2024-03-18 https://precivityad.com/news/cn-diagnostics-llc-announces-investment-from-eisai-inc monthly 0.5 2024-03-06 https://precivityad.com/news/researchers-identify-new-cost-savings-and-accuracy-of-cn-diagnostics-blood-tests-to-enable-healthcare-providers-to-better-identify-alzheimers-disease monthly 0.5 2023-11-16 https://precivityad.com/news/new-research-shows-new-research-shows-high-accuracy-of-precivity-blood-biomarkers-in-the-evaluation-of-brain-amyloid-inpre-clinical-alzheimers-disease monthly 0.5 2023-11-08 https://precivityad.com/news/c2n-diagnostics-introduces-next-generation-fluid-biomarker-to-the-field-of-alzheimers-disease-test-to-help-researchers-trackneurofibrillary-tau-tangle-pathology monthly 0.5 2023-10-25 https://precivityad.com/news/on-world-alzheimers-daycn-diagnostics-precivityad2-blood-test-expands-reach monthly 0.5 2023-09-21 https://precivityad.com/news/cn-diagnostics-releases-the-precivityad2-blood-test-for-clinical-care-a-robust-assay-with-high-concordance-to-amyloid-pet-and-csf monthly 0.5 2023-08-29 https://precivityad.com/news/evidence-shows-healthcare-providers-use-c2n-diagnostics-precivityad-blood-test-to-help-affirm-alzheimers-disease-diagnosis-andchange-drug-treatment-decisionsnbsp-nbsp monthly 0.5 2023-08-08 https://precivityad.com/news/alzheimers-disease-community-benefits-as-cn-diagnostics-precivity-related-blood-biomarkers-demonstrate-robust-effectiveness-set-new-performance-standardnbsp monthly 0.5 2023-08-17 https://precivityad.com/news/c2n-diagnostics-used-in-clinical-trials-for-leqembi-for-alzheimers-disease-treatment-is-poised-to-support-medical-community-in-next-steps monthly 0.5 2023-08-08 https://precivityad.com/news/cn-diagnostics-building-on-recent-achievements-bolsters-executive-team-as-it-prepares-for-commercial-expansion-nbspnbsp monthly 0.5 2023-04-24 https://precivityad.com/news/cn-diagnostics-precivity-related-blood-biomarkers-shown-to-improve-diagnostic-accuracy-and-future-risk-prediction-of-alzheimers-disease-in-two-studies-presented-at-adpd-2023 monthly 0.5 2023-04-04 https://precivityad.com/news/cns-precivityad-blood-test-which-identifies-amyloid-pathology-as-an-aid-to-alzheimers-disease-diagnosis-further-demonstrates-its-high-accuracy-in-newly-published-research monthly 0.5 2023-03-29 https://precivityad.com/news/cn-diagnostics-announces-follow-on-investment-from-ghr-foundation-as-it-builds-on-success-in-novel-diagnostics-to-aid-in-alzheimers-disease-fightnbsp monthly 0.5 2023-03-23 https://precivityad.com/news/c2n-diagnostics-precivityad-and-precivityad2-blood-tests-at-ctad-2022highlight-the-potential-and-use-of-blood-based-biomarkersin-the-diagnosis-of-alzheimers-disease monthly 0.5 2023-08-15 https://precivityad.com/news/c2n-diagnostics-introduces-the-precivityad2-blood-test monthly 0.5 2022-12-08 https://precivityad.com/news/international-researchers-poised-to-learn-new-insights-about-c2n-diagnosticsblood-test-innovations-at-clinical-trials-on-alzheimers-disease-conference monthly 0.5 2022-11-17 https://precivityad.com/news/cn-diagnostics-marks-two-years-of-precivityad-blood-test-accomplishments monthly 0.5 2022-10-21 https://precivityad.com/news/cn-diagnostics-partners-with-grupo-fleury-to-bring-pioneering-blood-tests-to-brazil-for-advancing-brain-health monthly 0.5 2022-09-21 https://precivityad.com/news/independent-research-finds-underlying-method-for-c2ns-p-tau217-ratioblood-test-outperforms-other-tau-blood-tests-used-for-alzheimers-diagnoses monthly 0.5 2022-10-21 https://precivityad.com/news/c2n-diagnostics-and-healius-ltd-announce-partnership-to-bring-precivityad-and-related-brain-health-biomarkers-to-patients-in-australia monthly 0.5 2022-08-30 https://precivityad.com/news/ogmwasco1dbhwng7c6w5jztdy2h938 monthly 0.5 2022-08-23 https://precivityad.com/news/ctyxl9j8rbpsn1nlwd2lhammfktqu3 monthly 0.5 2022-08-01 https://precivityad.com/news/c2n-diagnostics-introduces-p-tau-multi-analyte-assay-for-research-use-only-to-advance-alzheimers-disease-and-brain-health-field monthly 0.5 2022-10-21 https://precivityad.com/news/jama-network-open-publishes-analysis-of-results-of-two-independent-studies-demonstrating-the-high-diagnostic-performance-of-the-precivityad-blood-test-for-alzheimers-disease monthly 0.5 2022-04-21 https://precivityad.com/news/c2n-achieves-a-hrefx-webdoc33f08c7f-651b-4a92-974a-04c722961c45-targetblankiso-134852016-certificationa-latest-development-for-leader-in-brain-health-sector monthly 0.5 2022-07-28 https://precivityad.com/news/c2n-begins-new-year-with-cap-accreditation-award-the-highest-standard-in-laboratory-practices monthly 0.5 2022-01-07 https://precivityad.com/news/major-research-findings-highlight-effectiveness-of-the-precivityad-blood-test-that-clinicians-use-to-aid-in-alzheimers-disease-diagnosis monthly 0.5 2021-11-12 https://precivityad.com/news/cn-opens-state-of-the-art-clia-lab-in-st-louis-as-alzheimers-disease-blood-diagnostic-test-bests-others-in-independent-comparison-studies-published-in-jama-neurology monthly 0.5 2021-09-22 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1632261565639-E5I8X1E2C8F98YC02I3Y/4340+Duncan+Ave.jpg News & Events - C₂N Opens State-of-the-Art CLIA Lab in St. Louis as Alzheimer’s Disease Blood Diagnostic Test Bests Others in Independent Comparison Studies Published in JAMA Neurology - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://precivityad.com/news/two-research-studies-bolster-method-that-c2ns-precivityad-blood-test-uses-to-aid-clinicians-in-alzheimers-disease-diagnoses monthly 0.5 2021-08-16 https://precivityad.com/news/blood-tests-could-help-screen-anticipated-flood-of-patients-seeking-new-alzheimers-drug monthly 0.5 2021-07-22 https://precivityad.com/news/peer-reviewed-journal-publishes-analytical-validation-results-for-theprecivityad-blood-test-which-can-help-clinicians-detect-alzheimers-disease monthly 0.5 2021-07-22 https://precivityad.com/news/peer-reviewed-journal-publishes-precivityad-blood-test-research-confirming-its-role-in-assisting-clinicians-in-alzheimers-diagnosis monthly 0.5 2021-05-20 https://precivityad.com/news/rhode-island-patients-now-have-access-tobreakthrough-alzheimers-diagnostic-blood-test monthly 0.5 2021-05-03 https://precivityad.com/news/c2nnamedfierce15of2021 monthly 0.5 2021-03-08 https://precivityad.com/news/precivityad-blood-tests-reach-expands-to-europe-and-california-following-initial-launch-test-detects-alzheimers-disease-pathology monthly 0.5 2020-12-10 https://precivityad.com/news/alzheimers-breakthrough monthly 0.5 2020-10-29 https://precivityad.com/news/aadf-announces-major-funding monthly 0.5 2020-10-27 https://precivityad.com/news/identification-of-p-tau217 monthly 0.5 2020-10-27 https://precivityad.com/news/c2n-diagnostics-receives-20m monthly 0.5 2020-10-27 https://precivityad.com/news/c2n-diagnostics-reports-high-accuracy monthly 0.5 2020-10-27 https://precivityad.com/newsletters daily 0.75 2025-11-20 https://precivityad.com/newsletters/ctad-2025 monthly 0.5 2025-11-20 https://precivityad.com/newsletters/c2n-makes-many-moves-as-it-advances-science monthly 0.5 2025-11-05 https://precivityad.com/newsletters/c2n-at-aaic-2025-in-toronto monthly 0.5 2025-07-23 https://precivityad.com/newsletters/c2n-at-adpd-2025-in-vienna monthly 0.5 2025-03-18 https://precivityad.com/newsletters/c2n-year-in-review monthly 0.5 2025-01-15 https://precivityad.com/newsletters/c2n-at-ctad-2024-in-madrid monthly 0.5 2024-10-22 https://precivityad.com/newsletters/jama-published-landmark-clinical-study-on-alzheimers-disease-diagnosis-using-the-precivityad2-blood-test monthly 0.5 2024-09-04 https://precivityad.com/newsletters/c2n-at-aaic-in-philadelphia-july-28aug-1 monthly 0.5 2024-07-16 https://precivityad.com/newsletters/join-our-c2n-diagnostics-team-at-the-16th-clinical-trials-on-alzheimers-disease-ctad-october-24-27-in-boston monthly 0.5 2023-10-18 https://precivityad.com/newsletters/join-our-c2n-diagnostics-team-at-aaic-2023 monthly 0.5 2023-06-30 https://precivityad.com/newsletters/join-our-c2n-diagnostics-team-at-the-15th-clinical-trials-on-alzheimers-disease-ctad-in-san-francisco-november-29-december-2 monthly 0.5 2022-11-17 https://precivityad.com/newsletters/cn-diagnostics-marks-two-years-of-precivityad-blood-test-accomplishments monthly 0.5 2022-10-24 https://precivityad.com/newsletters/yzaalir7nbwdpa7erpxqzv6hv9t1a5 monthly 0.5 2022-07-25 https://precivityad.com/newsletters/cn-diagnostics-takes-major-strides-in-advancing-brain-health-diagnostics monthly 0.5 2022-07-13 https://precivityad.com/newsletters/c2n-achieves-more-advancements-in-brain-health-diagnostics monthly 0.5 2022-03-31 https://precivityad.com/newsletters/two-independent-research-studies-bolster-method-that-cns-precivityad-blood-test-uses-to-aid-clinicians-in-alzheimers-disease-diagnoses monthly 0.5 2021-11-02 https://precivityad.com/newsletters/precivityad-test-success-leads-to-attention-and-growth monthly 0.5 2021-04-23 https://precivityad.com/newsletters/2020-marks-a-year-of-achievement-fora-hrefhttpsem-uiconstantcontactcomem-uiempageem-uiemail-targetblankc2nas-precivityad-blood-test monthly 0.5 2021-01-14 https://precivityad.com/media-coverage daily 0.75 2026-03-24 https://precivityad.com/media-coverage/alzforum-not-if-but-when-blood-p-tau217-clock-tells-time-of-ad-onset monthly 0.5 2026-03-02 https://precivityad.com/media-coverage/the-flow-how-biomarkers-and-blood-testing-are-transforming-early-alzheimers-detection monthly 0.5 2026-01-05 https://precivityad.com/media-coverage/360dx-c2n-diagnostics-receives-lab-permit-from-ny-state monthly 0.5 2025-11-26 https://precivityad.com/media-coverage/st-louis-magazine-c2n-expansion-into-former-goodwill-building-boosts-st-louis-bioscience-startup-ecosystem monthly 0.5 2025-09-04 https://precivityad.com/media-coverage/patient-care-novel-plasma-assay-that-selectively-detect-tau-characteristics-will-refine-clinical-study-of-alzheimers-disease monthly 0.5 2025-08-18 https://precivityad.com/media-coverage/360dx-c2n-diagnostics-inks-asia-distribution-deal-for-alzheimers-test-with-archerfish-precision-dx monthly 0.5 2025-08-18 https://precivityad.com/media-coverage/360dx-c2n-diagnostics-c2n-emtbr-tau243-and-c2n-p-tau-maa-tests monthly 0.5 2025-08-18 https://precivityad.com/media-coverage/pharmaexeccom-the-fight-for-alzheimers-disease-funding monthly 0.5 2025-08-18 https://precivityad.com/media-coverage/scitechdaily-new-blood-test-detects-alzheimers-and-tracks-its-progression-with-92-accuracy monthly 0.5 2025-05-13 https://precivityad.com/media-coverage/fierce-biotech-samsung-backs-alzheimers-blood-test-developer-c2n-diagnostics-with-10m monthly 0.5 2025-05-13 https://precivityad.com/media-coverage/healio-blood-rests-may-improve-decision-making-in-alzheimers-disease monthly 0.5 2025-02-18 https://precivityad.com/media-coverage/philanthropy-news-digest-mjff-awards-15-million-to-c2n-diagnostics-for-neurological-research monthly 0.5 2025-01-24 https://precivityad.com/media-coverage/washington-post-alzheimers-patients-and-their-families-hear-a-new-word-progress monthly 0.5 2024-10-18 https://precivityad.com/media-coverage/medical-device-network-c2n-receives-funding-for-alzheimers-disease-testing-platform monthly 0.5 2024-10-18 https://precivityad.com/media-coverage/nih-research-matters-accurate-blood-test-for-alzheimers-disease monthly 0.5 2024-08-15 https://precivityad.com/media-coverage/usa-today-how-a-new-blood-test-technology-could-change-alzheimers-treatment-forever monthly 0.5 2024-08-12 https://precivityad.com/media-coverage/st-louis-post-dispatch-a-st-louis-firm-races-to-diagnose-alzheimers-faster monthly 0.5 2024-08-12 https://precivityad.com/media-coverage/the-clinical-trial-vanguard-c2n-diagnostics-partners-with-precivity-alzheimers-blood-test-expansion-in-japan monthly 0.5 2024-05-02 https://precivityad.com/media-coverage/fierce-biotech-eisai-to-drop-up-to-15m-on-c2n-diagnostics-to-boost-the-reach-of-alzheimers-disease-blood-tests monthly 0.5 2024-03-07 https://precivityad.com/media-coverage/fierce-biotech-study-shows-a-front-line-alzheimers-blood-test-could-be-as-accurate-as-spinal-fluid-exams monthly 0.5 2024-03-02 https://precivityad.com/media-coverage/360dx-alzheimers-biomarker-research-pushing-plasma-p-tau217-to-the-fore monthly 0.5 2024-02-13 https://precivityad.com/media-coverage/alforum-ad-blood-tests-are-here-now-lets-grapple-with-how-to-use-them monthly 0.5 2024-02-08 https://precivityad.com/media-coverage/npr-blood-tests-can-help-diagnose-alzheimers-if-theyre-accurate-enough-not-all-are monthly 0.5 2024-01-12 https://precivityad.com/media-coverage/medical-device-news-c2ns-precivity-blood-biomarker-test-shows-promise-in-alzheimers-screening monthly 0.5 2024-01-12 https://precivityad.com/media-coverage/medscape-novel-tau-blood-biomarker-shows-promise monthly 0.5 2024-01-12 https://precivityad.com/media-coverage/proactive-biovie-says-blinded-data-points-to-hopeful-alzheimers-treatment-potential monthly 0.5 2024-01-12 https://precivityad.com/media-coverage/genomeweb-c2n-diagnostics-mtbr-tau monthly 0.5 2024-01-12 https://precivityad.com/media-coverage/healio-participation-in-digital-cognitive-test-biomarker-assays-linked-to-ad-study-enrollment monthly 0.5 2024-01-12 https://precivityad.com/media-coverage/fierce-biotech-c2n-diagnostics-launches-revamped-alzheimers-blood-test monthly 0.5 2023-08-24 https://precivityad.com/media-coverage/medical-device-network-c2n-launches-new-precivityad-blood-test monthly 0.5 2023-08-23 https://precivityad.com/media-coverage/alzheimers-news-today-precivityad-test-for-alzheimers-guided-clinical-decision-making monthly 0.5 2023-08-14 https://precivityad.com/media-coverage/being-patient-c2ns-alzheimers-blood-test-in-phils-journal monthly 0.5 2023-08-10 https://precivityad.com/media-coverage/medpage-today-alzheimers-blood-tests-may-improve-primary-care-diagnoses monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/st-louis-business-journal-award-to-c2n monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/stat-we-finally-have-new-alzheimers-drugs-how-do-we-decide-who-gets-them monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/the-wall-street-journal-new-blood-tests-offer-possibly-early-detection-of-cancer-and-alzho monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/fierce-biotech-c2ns-amyloid-and-tau-detecting-alzheimers-blood-test-outperforms-other-screening-tools monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/lab-pulse-c2n-diagnostics-announces-study-confirming-accuracy-of-test-for-alzheimers-diagnosis monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/is-it-alzheimers-families-want-to-know-and-blood-tests-may-offer-answers monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/is-it-alzheimers-this-revolutionary-blood-test-gives-doctors-an-easy-way-to-tell monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/clia-certified-alzheimers-blood-test-gets-high-marks-in-global-study monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/the-davos-alzheimers-collaborative-launches-early-detection-effort monthly 0.5 2022-05-06 https://precivityad.com/media-coverage/a-new-era-of-diagnosis-for-alzheimers-disease-scientists-study-blood-tests-for-dementia monthly 0.5 2023-08-02 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1651243387540-YX314T8U8LGMI7UZM9EB/USATSI_18162637.jpg Media Coverage - USA Today: A new era of diagnosis for Alzheimer's disease': Scientists study blood tests for dementia https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1651243389389-33KASVAA8FDBC2JH0G81/USATSI_18162629.jpg Media Coverage - USA Today: A new era of diagnosis for Alzheimer's disease': Scientists study blood tests for dementia https://precivityad.com/media-coverage/431ix7gom967nxy5kegcbwyl2sqx0a monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/st-louis-based-cn-diagnostics-has-a-blood-test-for-alzheimers-disease-thats-now-in-the-market monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2021/06/13/aduhelm-approval-amplifies-amyloid-assays monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2021/06/11/c2n-building-case-for-alzheimers-dx-as-aducanumab-approval-promises-to-impact-testing-space monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2021/06/09/bioworld-medtech-article-approval-of-aducanumab-paves-way-for-alzheimers-blood-tests monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2021/02/15/2021-02-15-2021-2-18-c2n-diagnostics-has-brought-its-alzheimers-blood-test-to-market-now-it-wants-to-expand-in-st-louis-and-beyond monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2021/02/07/2021-02-07-2021-2-18-the-other-pandemicnbsp-what-to-do-about-the-coming-alzheimers-crisis monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2021/02/04/2021-02-04-2021-2-18-detecting-alzheimers-gets-easier-with-a-simple-blood-test monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2021/01/28/2021-01-28-2021-2-18-blood-based-diagnostics-will-be-critical-to-a-comprehensive-national-alzheimers-response monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2021/01/06/2021-01-06-2021-1-8-alzheimers-blood-tests-big-breakthroughs-in-2020 monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2020/12/27/2020-12-27-2021-1-8-covid-19-wasnt-the-only-medical-story-this-year-heres-what-you-missed-in-2020 monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2020/12/23/2020-12-23-2021-1-8-the-biggest-science-news-in-2020 monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2020/12/09/2020-12-09-2020-12-8-precivityad-blood-tests-reach-expands-to-europe-and-california-following-initial-launch-test-detects-alzheimers-disease-pathology monthly 0.5 2020-12-09 https://precivityad.com/media-coverage/2020/12/02/2020-12-02-2020-12-1-first-blood-test-to-help-diagnose-alzheimers-goes-on-sale monthly 0.5 2020-12-02 https://precivityad.com/media-coverage/2020/11/17/2020-11-17-2020-11-17-first-alzheimers-blood-test-rolled-out-for-clinical-use-in-us monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2020/11/17/2020-11-17-2020-11-17-the-rising-tide-of-scientific-innovation-biotech-in-2020-and-beyond monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2020/11/02/2020-11-02-2020-12-14-first-alzheimers-blood-test-rolled-out-for-clinical-use-in-us monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/2020/11/02/2020-11-02-2020-12-14-the-rising-tide-of-scientific-innovation-biotech-in-2020-and-beyond monthly 0.5 2023-08-02 https://precivityad.com/media-coverage/category/Media+Coverage monthly 0.5 https://precivityad.com/media-coverage/category/Uncategorized monthly 0.5 https://precivityad.com/media-coverage/category/Press+Releases monthly 0.5 https://precivityad.com/webinars daily 0.75 2024-09-06 https://precivityad.com/webinars/w7saiq6lrgz2jd2g2z91wvhumh6tt5-9zzmt-xs5z4 monthly 0.5 2024-11-04 https://precivityad.com/webinars/w7saiq6lrgz2jd2g2z91wvhumh6tt5-9zzmt monthly 0.5 2024-09-06 https://precivityad.com/webinars/1m7um8l19ig1mvdajb7kxii8kawwg5 monthly 0.5 2023-10-04 https://precivityad.com/webinars/w7saiq6lrgz2jd2g2z91wvhumh6tt5 monthly 0.5 2024-04-08 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1623334185333-5U4OZB208YGEBVWPYIR5/Holtzman-251x360.jpeg Webinars - Diagnostic Tools & The New Blood Test - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1623334297699-T35NBKDKIX1JB934VQ6X/Smith-251x360.jpeg Webinars - Diagnostic Tools & The New Blood Test - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://precivityad.com/webinars/b00wrb8rtwpgv9en7jzt7zo2pipe7e monthly 0.5 2021-07-12 https://precivityad.com/patients daily 0.75 2025-03-12 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1603745315514-FXHP2JIH7GOCCSD2V0YJ/Report_shutterstock_404762026.jpg PrecivityAD® https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1600121324949-6Z9TZ2BNVUVD7ARKC94G/shutterstock_250522258.jpg PrecivityAD® - Talking to Your Healthcare Provider This printable flyer has more information on the PrecivityAD® test, which is only available by a healthcare provider’s order. Talk to your healthcare provider to see if the PrecivityAD® test is right for you. https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1601483192301-RLGZME851ESKCA6J7PPV/Icon-vile-keyline.png PrecivityAD® https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1601483209255-Q9YKTE1WP43NIS9N0AZX/Icon-machine-blue.png PrecivityAD® https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1600204478499-3EW092IMOH0DXSVOKCFD/Icon-report-keyline.png PrecivityAD® https://precivityad.com/cost-billing daily 0.75 2026-02-25 https://precivityad.com/privacy-policy daily 0.75 2020-10-28 https://precivityad.com/hipaa-notice daily 0.75 2020-10-28 https://precivityad.com/resources-old daily 0.75 2020-10-28 https://precivityad.com/healthcare-providers daily 0.75 2026-03-12 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/f5ce3da9-90f0-42c1-8e38-8d45d15bd51c/3872_C2N_Req_Form_21March2023.jpg PrecivityAD® - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1600292090672-2CW2UDKK5UU965DQZG2A/Photo+1.jpg PrecivityAD® - Our Technology Platform PrecivityAD® Test Platform: Based on C₂N’s proprietary Stable Isotope Spike Absolute Quantitation (SISAQ™) methodology, the PrecivityAD® test quantifies plasma biomarkers for neurodegenerative conditions using state-of-the-art sample preparation, liquid chromatographic separation, and mass spectrometry quantification technologies. The SISAQ™ methodology is a proprietary C₂N platform that enables measurement of absolute concentrations of peptides from multiple proteins in biological fluids. This mass spectrometry-based technique identifies and quantifies peptides with a high degree of specificity and precision. Multiple proteomic applications exist for this platform. By multiplexing, it is feasible to measure several biomarkers to create a multianalyte panel of plasma biomolecules (peptides, proteins, lipids, mono- and polysaccharides) that may one day help distinguish among the different classes of neurocognitive disorders. C₂N’s PrecivityAD® blood test is derived from this core platform methodology. https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1609975483560-NM9EN8D0IM359TGD1SG1/Blood-result-distribution.png PrecivityAD® https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1603745783511-6EJYQ9QNBN5M8AIS7MAW/Report_shutterstock_404762026.jpg PrecivityAD® https://precivityad.com/contact-us daily 0.75 2025-10-08 https://precivityad.com/hipaa-notice-1 daily 0.75 2020-10-26 https://precivityad.com/terms-of-use daily 0.75 2020-10-28 https://precivityad.com/partners daily 0.75 2023-08-28 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1605333257249-Q3Q5S3BOZUN5LAN5BYVN/NIA About Partnership https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1605333388828-FKR1CM6ZEI5ZRM79KZQM/Knight+ADRC About Partnership https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1605334217036-OB9HLMQPF5ZMAD41XOS9/addf_logo.png About Partnership https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1605334504209-4A80PU5HBQQ2ME90E2YL/ghr-logo.png About Partnership https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1605334355025-1SWVJ7JC85EUGI81RYTJ/BrightFocus About Partnership https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1605335076619-OSOX724MPPZXX85YTTE1/IDEAS-logo About Partnership https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1600372337223-3ZLC1TK4NK3P877HI7FR/200722_naunheim_c2n_038.jpg About Partnership https://precivityad.com/order-the-test daily 0.75 2025-11-04 https://precivityad.com/patient-caregiver-faq daily 0.75 2026-02-27 https://precivityad.com/benefits-of-an-early-diagnosis daily 0.75 2023-06-16 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1603384642061-0M7UPGI6D7R3GWDOD1CA/shutterstock_130170572.jpg Benefits of an Early Diagnosis https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1603384750341-MGAS6XVRUCEUVS140ZV3/shutterstock_420804580.jpg Benefits of an Early Diagnosis https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1603385292896-XUAM0MI1N87Z995UU7PR/shutterstock_566980555.jpg Benefits of an Early Diagnosis https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1603386352677-BYLVR89FOMUNFZBA7ETX/shutterstock_1448567009.jpg Benefits of an Early Diagnosis https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1603386300809-520A7T462FK1WAAV2LPE/placeholder.jpg Benefits of an Early Diagnosis https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1603385005805-IGD7B5DPVZ6ATDT8C6KA/shutterstock_371809282.jpg Benefits of an Early Diagnosis https://precivityad.com/healthcare-providers-faqs daily 0.75 2025-10-01 https://precivityad.com/apoe-genetic-testing-healthcare-providers daily 0.75 2024-09-12 https://precivityad.com/apoe-genetic-testing-patients daily 0.75 2023-08-14 https://precivityad.com/resources-apoe-genetic-testing daily 0.75 2020-12-04 https://precivityad.com/resources-for-physicians daily 0.75 2020-12-04 https://precivityad.com/resources-alzheimers-disease daily 0.75 2020-12-04 https://precivityad.com/resources-clinical-trials daily 0.75 2021-04-12 https://precivityad.com/publications daily 0.75 2023-08-09 https://precivityad.com/partnership-opportunities daily 0.75 2023-08-17 https://precivityad.com/video daily 0.75 2025-03-12 https://precivityad.com/2022clinicalclientsurvey daily 0.75 2022-06-03 https://precivityad.com/portal daily 0.75 2024-03-28 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/5b31b9dc-87fb-45ad-9b5a-69841a82b5c6/PrecivityAD2_TM_Color_Positive.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/7efbaa81-94bc-419b-82c8-1c30cc21243c/3872_AD2_Test_Spec_Thumbnail_27July2023.jpg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/8aed1dc6-6db3-40c1-af23-a84e3b4d2b05/Precivity-ApoE_TM_Color_Positive.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/eaeaec30-d7f3-4cbb-b905-dd1b284ec858/3872_ApoE_Test_Spec_Thumbnails_10July2023.jpg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/ef624b23-4aa4-4634-840c-b7a28d1f0270/Precivity_AD_R_Color_Positive.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/622d7a48-f3af-4f7e-bbdf-c622e2ab1703/3872_PAD_Test_Spec_Thumbnails_10July2023.jpg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/c6461914-7456-4dc6-88b8-fe57aea3632d/step1_icon_RGB.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/40ca7d3f-3471-4c8e-b63c-d8972642fb36/step2_icon_RGB.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/e60a4754-2895-43d2-95f8-5430cc49b35e/step3_icon_RGB.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1666376384053-39R9R6GCSNZ2W4DPWG4W/C2N_logo_V_RGB_thumbnail.png https://precivityad.com/precivityad2-patients daily 0.75 2025-03-12 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/c6461914-7456-4dc6-88b8-fe57aea3632d/step1_icon_RGB.png PrecivityAD2™ for Patients - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/6d7a6cec-0d54-4238-94cd-efd924a65a32/step2_icon_RGB.png PrecivityAD2™ for Patients - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/e60a4754-2895-43d2-95f8-5430cc49b35e/step3_icon_RGB.png PrecivityAD2™ for Patients https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/bd6eddbb-04c9-4d38-b1b9-756167951363/AdobeStock_596398152.jpeg https://precivityad.com/financial-assistance daily 0.75 2025-02-14 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/9b091576-03de-4634-86ba-edb1ab13a728/200722_naunheim_c2n_010.jpg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/ef1f8e2f-af20-4411-bfa3-d35d2a15819c/FAP_north+america.png https://precivityad.com/homepage daily 1.0 2026-03-11 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/59db4a63-ad8d-4314-818a-69a5f60512e3/blood+drop+with+disclaimer.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/a91b206c-0831-4414-b214-e556b61dcb43/pad-button.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/79fc2147-ea96-4751-bb17-36f55e2620d2/pad2-button.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/4b1004e5-7de1-49d4-87a6-519102f310e7/papoe-button.png https://precivityad.com/publications-clinical-use daily 0.75 2025-10-14 https://precivityad.com/publications-research-trials daily 0.75 2025-07-25 https://precivityad.com/schedule-blood-draw daily 0.75 2024-03-06 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/596ae8ae-cc3c-4a26-971b-f53d7aae230d/Blood+Draw_PAD2+Page.jpeg https://precivityad.com/precivityad2-hcp daily 0.75 2025-11-24 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/836ac5a9-352e-41bc-9d6a-75687063e4ad/blood+drop+with+disclaimer.jpg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/b64f1ff4-8d11-4b3a-a5c4-219bcc6f0398/bullseye.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/0972be52-b679-4169-bd7c-8936f6a2b92c/person+with+heart+3.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/42e142b4-9fc6-47bd-b59e-b1b0bc59f5e9/vial2.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/66b229f4-7e61-4ae0-9d38-fe71fe9f46cd/test+results.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1706554117030-MUEBFWP6IHU6UEYPU0DR/image-asset.jpeg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/596ae8ae-cc3c-4a26-971b-f53d7aae230d/Blood+Draw_PAD2+Page.jpeg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/5908ceef-df80-4ab1-acec-92c4a211ec62/map.jpg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/0bfc611d-434c-4e27-a927-185749ee307f/home.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/5c6a3f03-8f79-43bf-b40a-52f8b8bd84f3/stethoscope.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/c1a221b1-9020-4e3f-9dd8-ebe7319dc2d3/AdobeStock_374635193.jpeg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/a768f17c-3be0-427f-b608-543c94ee86a0/blood+test.jpg https://precivityad.com/international-partners daily 0.75 2026-03-10 https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/73d9ee7b-98f2-48ab-8d99-ed0c2d46edda/MC_SUBRANDS_LABORATORIES_BLACK_RGB%5B45%5D.jpg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/06825852-c123-421c-b658-d43751e88887/Healius_Logo_Primary_Watermelon%2BDarkBlue_WEB+%282%29%5B29%5D.jpg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/6f7af905-25db-4063-af20-433df99897df/grupo_fleury-logo-EDIT.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/7dcc6fb9-d5e3-4c60-80b4-4bacc954e82c/Toronto-Memory-Program-Revised-Logo_FINAL-%28Dec-2012%29.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/52d534a4-3c8e-4527-8590-10937ffaba02/Codex+LOGO_horizontal-cs6+%28black+logo%29.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1859c496-1d21-4425-bffb-a15ff5358c69/DR+DANGS+LAB+LOGO+03+EDIT.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/1a08f3be-386a-4589-8d55-d16ef896cd5f/MedicalLink_logo_RGB-JPG-01%5B28%5D.jpg https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/b2c23266-77da-46c1-b116-89baab3572b0/BeauBrain_CI_934x334.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/ba76bae3-64cd-44a3-b227-2888d1344de8/ML_completo-EDIT.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/c0dc9761-9972-4786-9f36-2bebfb02efc2/Accuserv.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/048e9c6c-578b-4b87-a35b-aa1ec732d4b3/Archerfish-Brandmark-2025_Full-Colour_500px%5B90%5D-EDIT.png https://images.squarespace-cdn.com/content/v1/5f5f9aa2954456537a28b45f/cc2652ce-24bd-46c5-af07-7af6cb6bc071/veritas-h-EDIT.jpg https://precivityad.com/california-declaration-of-compliance daily 0.75 2026-03-12